These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17668546)

  • 21. Treatment of facial verrucae with topical imiquimod cream in a patient with human immunodeficiency virus.
    Cutler K; Kagen MH; Don PC; McAleer P; Weinberg JM
    Acta Derm Venereol; 2000; 80(2):134-5. PubMed ID: 10877136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of Bowen's disease with topical 5% imiquimod cream: retrospective study.
    Rosen T; Harting M; Gibson M
    Dermatol Surg; 2007 Apr; 33(4):427-31; discussion 431-2. PubMed ID: 17430376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrence rate of superficial basal cell carcinoma following successful treatment with imiquimod 5% cream: interim 2-year results from an ongoing 5-year follow-up study in Europe.
    Gollnick H; Barona CG; Frank RG; Ruzicka T; Megahed M; Tebbs V; Owens M; Stampone P
    Eur J Dermatol; 2005; 15(5):374-81. PubMed ID: 16172048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imiquimod reactivation of lichen planus.
    Domingues E; Chaney KC; Scharf MJ; Wiss K
    Cutis; 2012 Jun; 89(6):276-7, 283. PubMed ID: 22838091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histologic features mimicking mycosis fungoides induced by imiquimod, 5%: a potential pitfall for dermatopathologists.
    Altamura D; Simonacci F; Hirbod T; Arkoumani E; Verdolini R
    JAMA Dermatol; 2014 Nov; 150(11):1236-7. PubMed ID: 25133432
    [No Abstract]   [Full Text] [Related]  

  • 26. [Erythema multiforme due to 5% imiquimod cream].
    García-Arpa M; Rodríguez-Vázquez M; Delgado Portela M; Vera Iglesias E
    Actas Dermosifiliogr; 2010 Jul; 101(6):551-2. PubMed ID: 20738976
    [No Abstract]   [Full Text] [Related]  

  • 27. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies.
    Geisse J; Caro I; Lindholm J; Golitz L; Stampone P; Owens M
    J Am Acad Dermatol; 2004 May; 50(5):722-33. PubMed ID: 15097956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effective combination of photodynamic therapy and imiquimod 5% cream in the treatment of actinic keratoses: three cases.
    Held L; Eigentler TK; Leiter U; Garbe C; Berneburg MJ
    Biomed Res Int; 2013; 2013():102698. PubMed ID: 23484071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of actinic cheilitis with imiquimod 5% and a retractor on the lower lip: clinical and histological outcomes in 5 patients.
    McDonald C; Laverick S; Fleming CJ; White SJ
    Br J Oral Maxillofac Surg; 2010 Sep; 48(6):473-6. PubMed ID: 19836865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of topical imiquimod for the treatment of actinic keratosis: a status report.
    Del Rosso JQ
    Cutis; 2005 Oct; 76(4):241-8. PubMed ID: 16315560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generalized psoriasis induced by topical treatment of actinic keratosis with imiquimod.
    Fanti PA; Dika E; Vaccari S; Miscial C; Varotti C
    Int J Dermatol; 2006 Dec; 45(12):1464-5. PubMed ID: 17184267
    [No Abstract]   [Full Text] [Related]  

  • 32. Low incidence of new actinic keratoses after topical 5% imiquimod cream treatment: a long-term follow-up study.
    Stockfleth E; Christophers E; Benninghoff B; Sterry W
    Arch Dermatol; 2004 Dec; 140(12):1542. PubMed ID: 15611446
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of flat warts with 5% imiquimod cream.
    Kim MB; Ko HC; Jang HS; Oh CK; Kwon KS
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1349-50. PubMed ID: 17062069
    [No Abstract]   [Full Text] [Related]  

  • 34. Imiquimod-induced regression of actinic keratosis is associated with infiltration by T lymphocytes and dendritic cells: a randomized controlled trial.
    Ooi T; Barnetson RS; Zhuang L; McKane S; Lee JH; Slade HB; Halliday GM
    Br J Dermatol; 2006 Jan; 154(1):72-8. PubMed ID: 16403097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erosive cheilitis after facial application of imiquimod 5% cream.
    Campanelli A; Lübbe J
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1429-30. PubMed ID: 17958863
    [No Abstract]   [Full Text] [Related]  

  • 36. Erythema multiforme induced by imiquimod 5% cream.
    Ballester I; Guijarro J; Silvestre JF; Niveiro M
    Int J Dermatol; 2014 Jul; 53(7):e347-8. PubMed ID: 24602041
    [No Abstract]   [Full Text] [Related]  

  • 37. Topical 5% imiquimod for the therapy of actinic cheilitis.
    Smith KJ; Germain M; Yeager J; Skelton H
    J Am Acad Dermatol; 2002 Oct; 47(4):497-501. PubMed ID: 12271290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical Imiquimod in the Treatment of Conjunctival Actinic Keratosis.
    Rowlands MA; Giacometti JN; Servat J; Materin MA; Levin F
    Ophthalmic Plast Reconstr Surg; 2017; 33(1):e21-e23. PubMed ID: 25853505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New and emerging topical approaches for actinic keratoses.
    Del Rosso JQ
    Cutis; 2003 Oct; 72(4):273-6, 279. PubMed ID: 14604078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imiquimod 5% cream induced psoriasis: a case report, summary of the literature and mechanism.
    Patel U; Mark NM; Machler BC; Levine VJ
    Br J Dermatol; 2011 Mar; 164(3):670-2. PubMed ID: 21062268
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.